Unlocking opportunities SEACare 2025: Gateway to Southeast Asia’s Thriving Healthcare Market and Strategic Collaboration
8
20250117
KUALA LUMPUR, Malaysia , Jan. 17, 2025 PRNewswire special lead SEACare 2025, the Southeast Asian
Healthcare & Pharmaceutical Exhibition, will return for its 25th ition from April 23 to 25, 2025 at the
Malaysia International Trade and Exhibition Centre (MITEC. As a reputable B2B trade platform, the
exhibition is creat by Qube Integrat Malaysia Sdn. Bhd. (Qube, Malaysia’s top event and exhibition
organizer, to closely connect Malaysian and international brands, manufacturers and service providers
in the healthcare and pharmaceutical fields with outstanding professional visitors, buyers and investors from around the world.
Witness by the Deputy Minister of Health of Malaysia
Qube and the Mical Device Authority of Malaysia sign a memorandum of agreement at the SEACare 2025 prelaunch event last year.
Witness by the Deputy Minister of Health of Malaysia, Qube and the Mical Device Authority of
Malaysia sign a memorandum of agreement at the SEACare 2025 prelaunch event last year.
Endors by the Malaysia External Trade must-have conditions when looking for a woocommerce development agency Development Corporation (MATRADE, SEACare 2025 is
uniquely position as a premier trade show that showcases Malaysia’s leadership in healthcare
innovation and excellence. SEACare sincerely invites mical device manufacturers who are interest in
expanding their business in Southeast Asia to jointly explore the market by leveraging the strategic
cooperation between the organizer and the Malaysian Mical Device Authority (MDA. Malaysia’s comprehensive regulatory framework provides MDAcertifi companies with fast approval facilities in multiple regional markets.
This strategic advantage makes SEACare 2025 an important
Platform for companies to expand their presence in Southeast Asia’s thriving healthcare market.
Richard Teo, Executive Chairman of Qube , said: “Malaysia’s healthcare and mical device industries
are growing rapidly, with mical device exports set calling list to reach RM28.1 billion in 2023. SEACare 2025 is
perfectly position to capitalise on this momentum, providing a key opportunity for companies to tap into the thriving Southeast Asian healthcare market and foster innovation and collaboration across the region Unlocking opportunities .